[1] | Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med, 2015, 372(9): 793-795. | [2] | Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD. Genome editing with engineered zinc finger nucleases. Nat Rev Genet, 2010, 11(9): 636-646. | [3] | Sun N, Zhao HM. Transcription activator-like effector nucleases (TALENs): a highly efficient and versatile tool for genome editing. Biotechnol Bioeng, 2013, 110(7): 1811-1821. | [4] | Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell, 2014, 157(6): 1262-1278. | [5] | Zetsche B, Gootenberg JS, Abudayyeh OO, Slaymaker IM, Makarova KS, Essletzbichler P, Volz SE, Joung J, van der Oost J, Regev A, Koonin EV, Zhang F. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell, 2015, 163(3): 759-771. | [6] | Fonfara I, Richter H, Bratovi? M, Le Rhun A, Charpentier E. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA. Nature, 2016, 532(7600): 517-521. | [7] | Abudayyeh OO, Gootenberg JS, Konermann S, Joung J, Slaymaker IM, Cox DBT, Shmakov S, Makarova KS, Semenova E, Minakhin L, Severinov K, Regev A, Lander ES, Koonin EV, Zhang F. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector.. Science, 2016, 353(6299): aaf5573. | [8] | East-Seletsky A, O'Connell MR, Knight SC, Burstein D, Cate JH, Tjian R, Doudna JA. Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection. Nature, 2016, 538(7624): 270-273. | [9] | Xu S, Cao SS, Zou BJ, Yue YY, Gu C, Chen X, Wang P, Dong XH, Xiang Z, Li K, Zhu MS, Zhao QS, Zhou GH. An alternative novel tool for DNA editing without target sequence limitation: the structure-guided nuclease. Genome Biol, 2016, 17: 186. | [10] | Burstein D, Harrington LB, Strutt SC, Probst AJ, Anantharaman K, Thomas BC, Doudna JA, Banfield JF. New CRISPR-Cas systems from uncultivated microbes. Nature, 2016, 542(7640): 237-241. | [11] | Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, Arkin AP, Lim WA. Repurposing CRISPR as an RNA- guided platform for sequence-specific control of gene expression. Cell, 2013, 152(5): 1173-1183. | [12] | Gilbert LA, Larson MH, Morsut L, Liu ZR, Brar GA, Torres SE, Stern-Ginossar N, Brandman O, Whitehead EH, Doudna JA, Lim WA, Weissman JS, Qi LS. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell, 2013, 154(2): 442-451. | [13] | Cheng AW, Wang HY, Yang H, Shi LY, Katz Y, Theunissen TW, Rangarajan S, Shivalila CS, Dadon DB, Jaenisch R. Multiplexed activation of endogenous genes by CRISPR- on, an RNA-guided transcriptional activator system. Cell Res, 2013, 23(10) |
[1] |
Bingzheng Wang, Chao Zhang, Jiali Zhang, Jin Sun.
Conditional editing of the Drosophila melanogaster genome using single transcripts expressing Cas9 and sgRNA
[J]. Hereditas(Beijing), 2023, 45(7): 593-601.
|
[2] |
Beiping Zeng, Hongen Xu, Lu Mao, Wenxue Tang.
Molecular diagnosis of hereditary deafness and application of stepwise testing strategy
[J]. Hereditas(Beijing), 2023, 45(1): 29-41.
|
[3] |
Meizhen Liu, Liren Wang, Yongmei Li, Xueyun Ma, Honghui Han, Dali Li.
Generation of genetically modified rat models via the CRISPR/Cas9 technology
[J]. Hereditas(Beijing), 2023, 45(1): 78-87.
|
[4] |
Xiaojun Zhang, Kun Xu, Juncen Shen, Lu Mu, Hongrun Qian, Jieyu Cui, Baoxia Ma, Zhilong Chen, Zhiying Zhang, Zehui Wei.
A CRISPR/Cas9-Gal4BD donor adapting system for enhancing homology-directed repair
[J]. Hereditas(Beijing), 2022, 44(8): 708-719.
|
[5] |
Chong Zhang, Zixuan Wei, Min Wang, Yaosheng Chen, Zuyong He.
Editing MC1R in human melanoma cells by CRISPR/Cas9 and functional analysis
[J]. Hereditas(Beijing), 2022, 44(7): 581-590.
|
[6] |
Yao Liu, Xianhui Zhou, Shuhong Huang, Xiaolong Wang.
Prime editing: a search and replace tool with versatile base changes
[J]. Hereditas(Beijing), 2022, 44(11): 993-1008.
|
[7] |
Yuting Han, Bowen Xu, Yutong Li, Xinyi Lu, Xizhi Dong, Yuhao Qiu, Qinyun Che, Ruibao Zhu, Li Zheng, Xiaochen Li, Xu Si, Jianquan Ni.
The cutting edge of gene regulation approaches in model organism Drosophila
[J]. Hereditas(Beijing), 2022, 44(1): 3-14.
|
[8] |
Guangwu Yang, Yuan Tian.
The F-box gene Ppa promotes lipid storage in Drosophila
[J]. Hereditas(Beijing), 2021, 43(6): 615-622.
|
[9] |
Dingwei Peng, Ruiqiang Li, Wu Zeng, Min Wang, Xuan Shi, Jianhua Zeng, Xiaohong Liu, Yaoshen Chen, Zuyong He.
Editing the cystine knot motif of MSTN enhances muscle development of Liang Guang Small Spotted pigs
[J]. Hereditas(Beijing), 2021, 43(3): 261-270.
|
[10] |
Na Wang, Zhilian Jia, Qiang Wu.
RFX5 regulates gene expression of the Pcdhα cluster
[J]. Hereditas(Beijing), 2020, 42(8): 760-774.
|
[11] |
Guoling Li, Shanxin Yang, Zhenfang Wu, Xianwei Zhang.
Recent developments in enhancing the efficiency of CRISPR/Cas9- mediated knock-in in animals
[J]. Hereditas(Beijing), 2020, 42(7): 641-656.
|
[12] |
Yingnan Chen, Jing Lu.
Application of CRISPR/Cas9 mediated gene editing in trees
[J]. Hereditas(Beijing), 2020, 42(7): 657-668.
|
[13] |
Siyuan Liu, Guoqiang Yi, Zhonglin Tang, Bin Chen.
Progress on genome-wide CRISPR/Cas9 screening for functional genes and regulatory elements
[J]. Hereditas(Beijing), 2020, 42(5): 435-443.
|
[14] |
Liwen Bao, Yiye Zhou, Fanyi Zeng.
Advances in gene therapy for β-thalassemia and hemophilia based on the CRISPR/Cas9 technology
[J]. Hereditas(Beijing), 2020, 42(10): 949-964.
|
[15] |
Minting Lin, Lulu Lai, Miao Zhao, Biwei Lin, Xiangping Yao.
Construction of a striatum-specific Slc20a2 gene knockout mice model by CRISPR/Cas9 AAV system
[J]. Hereditas(Beijing), 2020, 42(10): 1017-1027.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
|
|
|